Yes, clonidine is often combined with other antihypertensives such as ACE inhibitors or diuretics to achieve better control. However, dose adjustments and close monitoring are essential to avoid excessive blood-pressure reduction.
A 100 µg Catapres tablet typically bears the imprint “C100” on one side, followed by the manufacturer’s logo. Imprints can vary slightly between batches, so always verify with the pharmacy label.
Clonidine is not a prohibited substance in standard workplace drug-screening panels. It may appear as a prescribed medication on a medication-review form, which should be disclosed to the employer if required.
Yes, provided you carry the medication in its original packaging with the prescribing information. A copy of the prescription or a letter from your doctor can help address customs inquiries, especially when travelling outside the EU.
No. Crushed clonidine tablets may lead to rapid absorption and an unexpected fall in blood pressure. If swallowing is difficult, discuss alternative formulations (e.g., transdermal patches) with your prescriber.
Most patients see a measurable reduction within 2 weeks, but full stabilization and optimal dosing may require up to 4-6 weeks of careful titration and monitoring.
There are no strict food restrictions, but a high-salt diet can counteract the antihypertensive effect. Maintaining a balanced, low-sodium diet supports better blood-pressure control.
Sit or lie down immediately to prevent falls, and contact your healthcare provider. Severe dizziness may indicate hypotension requiring dose adjustment.
Yes, clonidine tablets are marketed under various generic names. The therapeutic content and dosage are the same, but branding may differ. Always confirm the strength (100 µg) when substituting.
Catapres is a brand-name medication that contains clonidine as its sole active ingredient. It is formulated as a pill that is typically supplied in a 100 µg strength. In the United Kingdom, Catapres is a prescription-only (POM) product regulated by the Medicines and Healthcare products Regulatory Agency (MHRA). It belongs to the heart and blood pressure therapeutic class and is primarily used to manage hypertension and certain withdrawal syndromes.
Clonidine is an α₂-adrenergic agonist. By stimulating α₂-receptors in the brainstem, it reduces sympathetic outflow from the central nervous system. This leads to:
The drug’s onset of action is usually within 30-60 minutes after oral intake, with peak blood-pressure-lowering effects occurring around 2-4 hours. The antihypertensive effect can last 12 hours or longer, allowing twice-daily dosing for most patients. Clonidine is partially metabolised in the liver and excreted unchanged in the urine; renal impairment may prolong its half-life.
Both uses are supported by the MHRA-approved product label and clinical guidelines such as those from NICE.
Clonidine has been investigated for a range of conditions beyond its approved uses. Evidence of sufficient quality to support routine off-label prescribing is limited, so any such use must be under specialist supervision and with explicit patient consent. Notable areas of research include:
Disclaimer: Off-label use of clonidine requires medical supervision and individualized risk assessment.
Practical advice: Patients should provide a full medication list, including over-the-counter drugs and herbal supplements, to their prescriber before starting Catapres.
Standard adult dosing (100 µg tablets):
Special populations:
Administration tips:
Overdose management:
Discontinuation:
This article provides educational information about Catapres (clonidine) and is not a substitute for professional medical advice. Treatment decisions, including use for unapproved indications, must be made under the guidance of a qualified healthcare provider. The content is intended for informational purposes and does not constitute medical recommendations. Always consult a physician before starting, stopping, or changing any medication regimen.
